CONTI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 6.939
EU - Europa 3.329
AS - Asia 1.558
SA - Sud America 105
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 8
Totale 11.967
Nazione #
US - Stati Uniti d'America 6.810
IT - Italia 732
DE - Germania 705
SG - Singapore 620
CN - Cina 476
SE - Svezia 370
IE - Irlanda 360
RU - Federazione Russa 285
GB - Regno Unito 214
UA - Ucraina 213
HK - Hong Kong 175
AT - Austria 136
CA - Canada 126
FI - Finlandia 103
BR - Brasile 80
IN - India 74
DK - Danimarca 62
TR - Turchia 56
ID - Indonesia 48
FR - Francia 39
VN - Vietnam 38
BE - Belgio 37
KR - Corea 20
NL - Olanda 17
CZ - Repubblica Ceca 14
EU - Europa 13
JP - Giappone 12
IR - Iran 10
CH - Svizzera 6
AR - Argentina 5
AU - Australia 5
EG - Egitto 5
HU - Ungheria 5
BD - Bangladesh 4
CL - Cile 4
PE - Perù 4
PL - Polonia 4
RO - Romania 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CO - Colombia 3
EC - Ecuador 3
ES - Italia 3
LV - Lettonia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SA - Arabia Saudita 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
DZ - Algeria 2
LT - Lituania 2
MA - Marocco 2
MX - Messico 2
PH - Filippine 2
PK - Pakistan 2
A1 - Anonimo 1
CY - Cipro 1
GR - Grecia 1
IL - Israele 1
IQ - Iraq 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MC - Monaco 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
UY - Uruguay 1
Totale 11.967
Città #
Ann Arbor 2.175
Chandler 534
Woodbridge 522
Frankfurt am Main 425
Singapore 407
Wilmington 375
Dublin 349
Houston 328
Fairfield 298
Ashburn 268
Jacksonville 266
Milan 253
Dearborn 250
Hong Kong 174
New York 155
Santa Clara 151
Seattle 138
Princeton 130
Vienna 127
Cambridge 109
Nanjing 95
Shanghai 76
Boardman 54
Lachine 51
Jakarta 46
Helsinki 41
Brussels 36
Lawrence 36
Beijing 33
Council Bluffs 33
Guangzhou 33
Nanchang 33
Dong Ket 30
Ottawa 30
Los Angeles 25
Pune 24
Rome 24
Shenyang 23
Fremont 22
Altamura 21
San Diego 20
Tianjin 19
Toronto 19
Andover 18
Falls Church 18
Carate Brianza 17
Munich 16
Norwalk 16
Dallas 15
Jiaxing 15
London 15
Edmonton 14
Hebei 14
Jinan 14
Nuremberg 14
Changsha 13
Monza 13
Brno 12
Como 12
Ningbo 12
Kunming 11
Mountain View 11
Zhengzhou 11
Leawood 10
Lissone 10
Detroit 9
Monmouth Junction 9
São Paulo 9
Chicago 8
Lappeenranta 8
Taizhou 8
Bergamo 7
Busto Arsizio 7
Belo Horizonte 6
Bologna 6
Gaziantep 6
Hangzhou 6
Hefei 6
Lecco 6
Pisa 6
Rozzano 6
Vadodara 6
Bielefeld 5
Bonn 5
Daejeon 5
Grafing 5
Nürnberg 5
Redmond 5
Rho 5
Ripalta Cremasca 5
Verona 5
Cairo 4
Capannori 4
Criciúma 4
Desio 4
Fuzhou 4
Haikou 4
Huizen 4
Johannesburg 4
Kumamoto 4
Totale 8.759
Nome #
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 403
QT interval and dispersion in drug-free anorexia nervosa adolescents: a case control study 362
QTc dispersion and interval changes in drug-free borderline personality disorder adolescents 360
Paradoxical Increase of plasma vitamin B12 and folates with disease severity in anorexia nervosa 304
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 303
Decreased whole-blood global DNA methylation is related to serum hormones in anorexia nervosa adolescents. 294
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 294
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 277
Irisin and BDNF serum levels and behavioral disturbances in Alzheimer's disease 272
Anorexia nervosa in adolescent girls and celiac disease serology 267
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 258
Can Signaling Molecules in Fibroblasts Detect Prodromal Alzheimer's Disease? 257
The one-carbon metabolism in anorexia nervosa of the restrictive type 254
Serum DBI and biomarkers of neuroinflammation in Alzheimer's disease and delirium 254
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 252
Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients? 236
Beta-amyloid-induced peripheral chemotactic response: what role in Alzheimer’s disease? 234
Donepezil modulates the endogenous immune response: implications for Alzheimer's disease 226
Stavudine Reduces NLRP3 Inflammasome Activation and Modulates Amyloid-β Autophagy 211
Diazepam binding inhibitor and dehydroepiandrosterone sulphate plasma levels in borderline personality disorder adolescents. 210
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 207
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients 199
Modulation of mapk phosphorylation in fibroblasts from alzheimer patients: erk involvment in glutamate transport and tau hyperphosporylation 189
Behavioural anomalies in neurodegenerative diseases: role of the immune response 188
Reduced fasting plasma levels of diazepam-binding inhibitor in adolescents with anorexia nervosa. 186
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 177
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 177
Anorexia nervosa of the restrictive type and celiac disease in adolescence 176
THE TOXIC EFFECT OF ABETA OLIGOMERS MAY BE REDUCED BY LIPID-BASED NANOPARTICLES IN HUMAN EX-VIVO MODELS 173
Lipid-based nanoparticles as a potential tool to reduce abeta toxic effect in a human cellular model 172
Increased Soluble APPalpha, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients 169
Beta-amyloid plasma levels in adolescents with anorexia nervosa of the restrictive type 167
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease? 166
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 166
Modulation of mapk phosphorylation in fibroblasts from alzheimer’s patients: the erk involvment in ad severity and eaat1 expression 166
Cholinesterase inhibitor use is associated with increased plasma levels of anti-Aβ 1-42 antibodies in Alzheimer's disease patients 164
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 160
Longitudinal effects on plasma abeta levels of imatinib, a gamma-secretase activating protein inhibitor 157
MAPK phosphorylation in fibroblasts from Alzheimer's disease patients: ERK involvement in EAAT1 expression and modulation with disease severity 156
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report 154
Plasma anti-amyloid-β autoantibodies in all Alzheimer disease types 152
Erk signalling modulates app metabolism, tau phosphorylation and eaat1 processing in fibroblasts from alzheimer’s patients 152
Affective states and pathology in adolescents with borderline personality 147
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 141
Role of donepezil in influencing endogenous immune response against abeta, an ex vivo and in vitro study 140
CLEARANCE OF BETA-AMYLOID OLIGOMERS BY PERIPHERAL MONOCYTES: FURTHER OBSERVATIONS REGARDING THE MODULATORY ROLE OF DONEPEZIL 140
BDNF serum levels with respect to multidimensional assessment in amyotrophic lateral sclerosis 139
Binding of lipid-based nanoparticles to plasma abeta: relevance for new therapeutic strategies in Alzheimer’s disease 138
New insights into the genetic etiology of Alzheimer's disease and related dementias 138
the MonzALS collaborative network 136
Behavioural Anomalies in Neurodegenerative Diseases: Role of the Immune Response 131
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 129
Novel therapeutic targets in neuropsychiatric disorders: the neuroepigenome 128
Acetyl-Cholinesterase Inhibitors Modulate The Autoimmune Response Against Beta-Amyloid 125
Whole-blood global DNA methylation and phenotypic variability in ALS 117
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 114
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion 114
Blood-based biomarkers of neuroinflammation in alzheimer’s disease: A central role for periphery? 113
Serum BDNF in amyotrophic lateral sclerosis decreases with disease severity 112
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 111
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset 110
Donepezil modulates the endogenous immune response in Alzheimer’s disease, an ex vivo and in vitro study 109
Further ex vivo evidence for a role of donepezil in the modulation of the immune response 109
Nilotinib or Dasatinib, but not Imatinib, might reduce Plasma Beta-Amyloid in Leukemia Patients : Implications gor Alzheimer’s Disease 107
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid 99
Immune response against beta-amyloid is modulated by acetyl-cholinesterase inhibitors 98
Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol 97
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease 86
Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer’s Disease Patients 62
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) 52
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 45
Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review 45
Core blood biomarkers of Alzheimer's disease: A single-center real-world performance study 42
Totale 12.675
Categoria #
all - tutte 41.533
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.533


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020315 0 0 0 0 0 0 0 0 0 140 152 23
2020/20211.970 127 82 204 248 186 162 201 148 166 178 102 166
2021/20221.111 139 145 124 110 71 67 55 50 48 61 85 156
2022/20231.924 192 525 218 207 131 281 36 108 129 25 44 28
2023/20241.311 62 60 71 66 161 323 233 46 59 23 18 189
2024/20251.872 171 277 212 113 238 166 207 141 304 43 0 0
Totale 12.675